Tait D. Shanafelt, MD
Interrupting Survival Signals in Early Stage CLL: A Maneuver to Prevent Progression Chronic Lymphocytic leukemia (CLL) is the most common sub-type of leukemia in the U.S. and is presently an incurable disease. Building on his preclinical and clinical observations, Dr. Shanafelt has opened a clinical trial of green tea extract in capsule form for patients […]
Read more